6Cotman CW, Iversen LL. Excitatory amino acids in the brain-focus on NMDA receptors[J]. Trends Neurosci,1987,25:263
7Banfi S, Dorigetti L. Experimental behavior studies with oxiracetam on different types of chronic cerebral impairment[J]. Clin Neuropharmacol,1984,7(suppl):768
8Saleto B, Linzmayerl L, Gmenberger J, et al. Double-blind,placebo-controlled clinical psychometric and neurophysiological investigations with syndrome of late life[J]. Neuropsychobiology.1985, 13:44
9Maina G, Fiori L, Toria R, et al. Oxiracetam in the treatment of primary degenerative and multi-infarct demenia: a double-blind, placebo-controlled study[J].Neuropsychobiology,1989,21:141
10Bottini G, Vallar G, Cappa S, et al. Oxiracetam in demania: a double-blind, placebo-controlled study[J]. Acta Neurol Scanol,1992,86:237
5Abe E, Murai S, Saito H, et al. Effects of nefiracetam, a novel pyrrolidone derivative,on brain monoaraine metabolisms in mice. J Neural T ransm GenSect, 1992,90 : 125-136.
